Prostaglandin inhibitors in the treatment of single-system langerhans cell histiocytosis: Pharmacologic rationale and report of two cases

Journal of Pediatric Hematology/Oncology

Volumn 30, Issue 10, 2008, Pages 778-780

  Goldberg, Scott A ^a   O'Connor, Stephen C ^b   Sprinz, Philippa G ^c,d  

^a Department of Pediatrics   (United States)

^b BAYSTATE MEDICAL CENTER   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BOSTON MEDICAL CENTER   (United States)

Author keywords

Langerhans cell histiocytosis; Naproxen; Prostaglandin inhibitors

Indexed keywords

NAPROXEN; PROTEIN S 100; T6 ANTIGEN; PROSTAGLANDIN RECEPTOR BLOCKING AGENT;

ARTICLE; BONE BIOPSY; BONE LESION; BONE SCINTISCANNING; CASE REPORT; CHILD; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; HISTIOCYTOSIS X; HUMAN; HUMERUS; INFANT; LEG PAIN; MALE; MONOTHERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SACROILIAC JOINT; SCHOOL CHILD; TREATMENT DURATION; TREATMENT OUTCOME; DISEASE FREE SURVIVAL; PATHOLOGY;

CHILD; DISEASE-FREE SURVIVAL; FEMALE; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; INFANT; MALE; NAPROXEN; PROSTAGLANDIN ANTAGONISTS;

EID: 58149232529     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e318184e6b3     Document Type: Article

References (22)

1. Laman JD, Leenen PJ, Annels NE, et al. Langerhans-cell histiocytosis "insight into DC biology". Trends Immunol. 2003;24: 190-196.
2. Fadeel B, Henter JI. Langerhans-cell histiocytosis: neoplasia or unbridled inflammation? Trends Immunol. 2003;24:409-410.
3. Egeler RM, D'Angio GJ. Langerhans cell histiocytosis. J Pediatr. 1995;127:1-11.
4. Raney RB Jr, D'Angio GJ. Langerhans' cell histiocytosis (histiocytosis X): experience at the Children's Hospital of Philadelphia, 1970-1984. Med Pediatr Oncol. 1989;17:20-28.
5. Howarth DM, Gilchrist GS, Mullan BP, et al. Langerhans cell histiocytosis: diagnosis, natural history, management, and outcome. Cancer. 1999;85:2278-2290.
6. Favara BE, Feller AC, Pauli M, et al. Contemporary classification of histiocytic disorders. The WHO Committee On Histiocytic/ Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society. Med Pediatr Oncol. 1997;29:157-166.
7. Gonzalez-Crussi F, Hsueh W, Wiederhold MD. Prostaglandins in histiocytosis-X. PG synthesis by histiocytosis-X cells. Am J Clin Pathol. 1981;75:243-253.
8. Arenzana-Seisdedos F, Barbey S, Virelizier JL, et al. Histiocytosis X. Purified (T6+) cells from bone granuloma produce interleukin 1 and prostaglandin E2 in culture. J Clin Invest. 1986;77:326-329.
9. Tashjian AH Jr. Editorial: prostaglandins, hypercalcemia and cancer. N Engl J Med. 1975;293:1317-1318.
10. Yoneda T, Mundy GR. Monocytes regulate osteoclast-activating factor production by releasing prostaglandins. J Exp Med. 1979;150: 338-350.
11. Bockman RS, Repo MA. Lymphokine-mediated bone resorption requires endogenous prostaglandin synthesis. J Exp Med. 1981;154: 529-534.
12. Brown RE. Cyclo-oxygenase-2 in the osteolytic lesions of Langer-hans cell histiocytosis. Med Pediatr Oncol. 2000;34:311.
13. McLean TW, Pritchard J. Langerhans cell histiocytosis and hypercalcemia: clinical response to indomethacin. J Pediatr Hematol Oncol. 1996;18:318-20.
14. Munn SE, Olliver L, Broadbent V, et al. Use of indomethacin in Langerhans cell histiocytosis. Med Pediatr Oncol. 1999;32:247-249.
15. Reichle A, Vogt T, Kunz-Schughart L, et al. Anti-inflammatory and angiostatic therapy in chemorefractory multisystem Langerhans' cell histiocytosis of adults. Br J Haematol. 2005;128:730-732.
16. Writing Group of the Histiocyte Society. Histiocytosis syndromes in children. Lancet. 1987;1:208-209.
17. Ghanem I, Tolo VT, D'Ambra P, et al. Langerhans cell histiocytosis of bone in children and adolescents. J Pediatr Orthop. 2003;23: 124-130.
18. Womer RB, Raney RB Jr, D'Angio GJ. Healing rates of treated and untreated bone lesions in histiocytosis X. Pediatrics. 1985;76: 286-288.
19. Broadbent V, Pritchard J, Davies EG, et al. Spontaneous remission of multi-system histiocytosis X. Lancet. 1984;1:253-254.
20. Gadner H, Grois N, Arico M, et al. Histiocyte Society. A randomized trial of treatment for multisystem Langerhans' cell histiocytosis. J Pediatr. 2001;138:728-734.
21. Henter JI, Karlen J, Calming U, et al. Successful treatment of Langerhans'-cell histiocytosis with etanercept. N Engl J Med. 2001; 345:1577-1578.
22. Goh NS, McDonald CE, MacGregor DP, et al. Successful treatment of Langerhans cell histiocytosis with 2-chlorodeoxyadenosine. Respirology. 2003;8:91-94.